Latest Imides Stories
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma.
ALISO VIEJO, Calif., Aug. 11, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has filed lawsuits in the U.S. District Court for the District of Delaware against Par Pharmaceutical, Inc.
ALISO VIEJO, Calif., July 1, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S.
BURLINGTON, Mass., Sept.
NEW ORLEANS, Dec. 7 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc.
'Renaissance' in use may lead to new treatments for controversial drug.
A British man Sunday said he will protest the government's refusal to compensate victims of the drug Thalidomide, administered to their mothers while pregnant.
NEW YORK, Aug. 25 /PRNewswire/ -- Beth R. Jacobson (formerly Beth R.
- To give a box on the ear to.